Grab Stock And 2 Penny Picks Built To Handle Higher Rates

US 10 year yields are hovering near recent highs as investors digest the latest Fed minutes. Higher funding costs can make it harder for highly leveraged penny stocks to stay alive, which puts balance sheet strength in the spotlight. That is exactly where the Elite Penny Stocks screener comes in. This article reveals three of the most resilient picks worth a closer look right now.

The three elite penny stocks in this article are just a starting sample, and the full screen surfaced 18 more companies with equally compelling balance sheet strength and narratives that are not covered here. To identify and analyze the highest conviction ideas tailored to your own risk tolerance and time horizon, head straight into the Elite Penny Stocks screener.

Grab Holdings (GRAB)

Overview: Grab Holdings runs a superapp across eight Southeast Asian countries that connects users to ride-hailing, food and package delivery, and a growing suite of digital finance tools through GrabPay and GrabFin, including PayLater, lending, and insurance. While mobility and deliveries are still its biggest revenue lines, the payments and lending ecosystem is the clearest link to the Elite Penny Stocks theme because it uses the company’s balance sheet to back scalable, higher margin financial services.

Operations: Grab generates most of its revenue from Deliveries at about US$2.0b and Mobility at about US$1.3b, with Financial Services contributing around US$430 million and the rest from smaller segments, across a broad Southeast Asian footprint led by Malaysia, Singapore, Indonesia, and the Philippines.

Market Cap: US$14.6b

Investors looking at Grab Holdings are getting more than a ride and food delivery platform. The real interest is the GrabPay and GrabFin engine, which uses external funding to back payments, PayLater, and lending products that can scale off its large customer base. Earnings growth has been very strong and margins have improved, yet analysts still see room between the current share price and their fair value and target estimates. At the same time, the entire liability base depends on higher risk external borrowing and the board is relatively young in tenure, so funding conditions and governance are important watchpoints. For investors willing to accept these risks, the combination of superapp reach and fintech upside deserves closer attention.

Grab Holdings is becoming a fintech engine as much as a ride and delivery platform, yet most attention still sits on the superapp story. To see how analysts connect the earnings profile, balance sheet exposure, and funding risk into one view, go straight to the analysis report for Grab Holdings

Build your own fintech and balance sheet shortlist

Grab Holdings and the two other stocks in this list came from a single screener, but the real edge is building filters that match your own checklist. Use our flexible Screener to combine valuation, future growth, balance sheet and risk metrics into your own watchlist, or start with any of our curated Investing Ideas.

Clover Health Investments (CLOV)

Overview: Clover Health Investments offers Medicare Advantage insurance plans to eligible seniors in the United States and uses its Clover Assistant software to help doctors manage chronic conditions more effectively. The recurring premiums from these health plans are the main engine behind the company’s connection to the Elite Penny Stocks theme, with the technology platform supporting cost control and member retention rather than driving the bulk of revenue.

Operations: Clover Health Investments generates about US$2.5b in revenue from its Insurance segment, almost entirely in the United States.

Market Cap: US$2.3b

Clover Health Investments may appeal to investors who prioritize cash resilience supported by recurring revenue. Its Medicare Advantage premiums create long-term member relationships that can support steadier cash flow, while the Clover Assistant platform is designed to help manage medical costs and support margins. At the same time, the company reports losses and relies fully on external funding rather than customer deposits, so discipline around medical costs and capital remains important. For investors seeking exposure to an insurer focused on GAAP profitability with a data-driven care model, and who are comfortable with regulatory and reimbursement risk, Clover Health could merit closer review within the Elite Penny Stocks group.

Clover Health’s recurring Medicare premiums and data driven care model may present a very different risk reward profile than the headline losses suggest. Get the full picture in the 5 key rewards and 1 important warning sign

ATRenew (RERE)

Overview: ATRenew runs a large-scale marketplace in China that buys, refurbishes, and resells pre-owned consumer electronics, while also providing services for third-party merchants to sell through its platforms. This focus on recycling and recommerce supports the Elite Penny Stocks theme because it relies on recurring inventory turnover rather than heavy hardware manufacturing, which can help preserve cash and support survivable growth.

Operations: ATRenew generates all of its reported revenue of about CN¥22.6b from its Retail - Electronics segment.

Market Cap: US$1.0b

ATRenew provides exposure to the shift toward recycling and secondhand electronics in China, with a business that turns used phones and devices into recurring cash flow instead of tying up money in factories. Recent results show net income of RMB 135.09 million for Q1 2026 and ongoing share buybacks, which together indicate management confidence in the business and its balance sheet. At the same time, ATRenew depends heavily on Chinese government trade-in subsidies, runs on thin margins, and faces rising competition and regulatory demands, so funding conditions and policy support are important factors. With Q2 2026 earnings due on 20 August and an expanded ReRe overseas push, investors who care about survivable growth may want to monitor how this cash-efficient model scales from here.

ATRenew’s cash-efficient recommerce engine, government trade-in support and thin margins create a mix many investors may be misreading. See how analysts frame the growth path in the analyst forecasts for ATRenew

Seeking Fresh Alternatives For Your Curiosity

New themes can gain momentum quickly, and the most attractive entry points may disappear before many investors notice. Scan fresh stock ideas while they are still under the radar and consider them before they become widely followed.

• Spot companies that may be building long-term cash engines before they appear in every headline by running the 20 high quality undiscovered gems and reviewing them before later momentum chasers arrive.
• Target businesses that appear more resilient and may help keep risk in check with the 79 resilient stocks with low risk scores so you are less exposed to fragile stocks if conditions suddenly tighten.
• Explore potential infrastructure and hardware opportunities by checking the 56 AI infrastructure stocks before additional capital enters and changes early pricing dynamics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com